Table 4.
Variable | Treatment Arm | ||
---|---|---|---|
Acetaminophen (n = 105) | Control (n = 110) | P Value | |
PCT, median (IQR), hours | 26.0 (21.3 to 30.9) | 25.1 (20.8 to 29.7) | .19 |
Clearance rate constant, median (IQR), hours | 0.27 (0.23 to 0.33) | 0.30 (0.25 to 0.35) | .025 |
Slope half-life, median (IQR), hours | 2.61 (2.12 to 3.0) | 2.30 (1.97 to 2.73) | .025 |
PC50, median (IQR), hours | 5.7 (3.7 to 9.1) | 4.8 (3.6 to 7.4) | .15 |
PC90, median (IQR), hours | 11.8 (9.4 to 15.2) | 11.4 (9.0 to 13.7) | .044 |
PC95, median (IQR), hours | 14.6 (11.7 to 18.0) | 13.9 (10.9 to 16.5) | .027 |
PC99, median (IQR), hours | 20.5 (17.4 to 24.4) | 19.8 (15.5 to 22.3) | .028 |
PCT: time in hours until first of 2 consecutive negative blood films. PC50: estimated time in hours for parasitemia to reduce by 50% of initial value. PC90: estimated time in hours for parasitemia to reduce by 90% of initial value. PC95: estimated time in hours for parasitemia to reduce by 95% of initial value. PC99: estimated time in hours for parasitemia to reduce by 99% of initial value.
Abbreviations: IQR, interquartile range; PCT, parasite clearance time.